Profile data is unavailable for this security.
About the company
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is a marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, own brands, retail healthcare, pharmacy, hospital and logistic services and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. It sources and supplies a range of surgical, medical, and pharmaceutical products. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics and Clinect.
- Revenue in NZD (TTM)13.63bn
- Net income in NZD276.85m
- Incorporated1922
- Employees5.20k
- LocationEBOS Group LtdLevel 7, 737 Bourke Street,, DocklandsCHRISTCHURCH 3008AustraliaAUS
- Phone+64 3338-0999
- Fax+64 3339-5090
- Websitehttps://www.ebosgroup.com/
Mergers & acquisitions
| Acquired company | EBO:NZC since announced | Transaction value |
|---|---|---|
| Green Cross Health Ltd | -15.16% | -- |
| Superior Pet Food Co Ltd | -14.40% | 51.66m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China Meheco Group Co Ltd | 7.92bn | 208.78m | 3.66bn | 8.39k | 17.52 | 1.38 | -- | 0.462 | 0.6183 | 0.6183 | 23.44 | 7.83 | 0.9224 | 4.58 | 2.28 | 4,180,309.00 | 2.96 | 3.40 | 6.72 | 7.76 | 11.22 | 14.15 | 3.21 | 2.93 | 1.22 | 8.89 | 0.335 | 28.22 | 3.28 | 4.60 | 42.45 | -7.46 | 6.72 | -1.02 |
| China Medical System Holdings Ltd | 1.81bn | 542.72m | 3.68bn | 5.70k | 6.82 | 1.06 | 6.23 | 2.03 | 1.06 | 1.06 | 3.53 | 6.83 | 0.4517 | 3.42 | 6.19 | 1,517,042.00 | 13.44 | 18.44 | 15.70 | 21.14 | 76.24 | 75.47 | 29.76 | 34.26 | 3.98 | -- | 0.0772 | 40.14 | -12.43 | 8.08 | -26.33 | 5.35 | 38.69 | 5.19 |
| Suzuken Co Ltd | 24.92bn | 302.93m | 3.84bn | 13.43k | 13.29 | 0.8818 | 11.49 | 0.154 | 355.82 | 355.82 | 29,434.28 | 5,361.97 | 2.01 | 15.63 | 4.51 | -- | 2.44 | 1.75 | 6.60 | 4.56 | 7.76 | 7.83 | 1.22 | 0.887 | 1.03 | -- | -- | 31.03 | 3.10 | 2.28 | 42.62 | -0.7993 | 12.14 | 6.28 |
| Alfresa Holdings Corporation | 29.84bn | 308.59m | 4.64bn | 11.77k | 14.09 | 0.8533 | 14.33 | 0.1554 | 155.44 | 155.44 | 14,905.27 | 2,566.51 | 2.05 | 17.16 | 4.60 | -- | 2.12 | 2.27 | 5.61 | 5.93 | 7.22 | 7.25 | 1.03 | 1.13 | 1.06 | -- | 0.0679 | 36.43 | 6.02 | 1.60 | 14.63 | -6.66 | 2.32 | 7.39 |
| Medipal Holdings Corp | 37.15bn | 433.00m | 5.33bn | 12.80k | 11.77 | 0.8072 | 7.44 | 0.1435 | 196.00 | 196.00 | 16,803.57 | 2,858.57 | 2.03 | 19.39 | 4.84 | -- | 2.95 | 2.65 | 8.17 | 7.43 | 6.93 | 6.83 | 1.45 | 1.34 | 1.06 | -- | -- | 28.51 | 5.91 | 2.26 | 6.88 | 3.84 | 0.9592 | 9.57 |
| China National Medicines Corp Ltd | 11.42bn | 494.61m | 5.93bn | 3.14k | 11.98 | 1.62 | -- | 0.519 | 2.90 | 2.90 | 67.05 | 21.51 | 1.61 | 11.21 | 6.58 | 16,122,340.00 | 7.57 | 7.32 | 14.41 | 15.03 | 7.63 | 8.15 | 4.70 | 4.31 | 1.77 | -- | 0.1271 | 30.04 | 9.23 | 5.11 | 9.26 | 8.85 | 1.84 | 16.38 |
| Jointown Pharmaceutical Group Co Ltd | 33.53bn | 489.48m | 6.42bn | 30.10k | 13.29 | 1.16 | -- | 0.1913 | 0.5469 | 0.5469 | 37.57 | 6.28 | 1.53 | 8.05 | 3.96 | 4,934,201.00 | 2.31 | 3.01 | 7.85 | 9.72 | 7.68 | 8.24 | 1.50 | 1.98 | 0.9782 | 3.50 | 0.5673 | 34.73 | 6.92 | 11.50 | 4.88 | 14.16 | -10.39 | 39.14 |
| EBOS Group Ltd | 13.63bn | 276.85m | 6.51bn | 5.20k | 23.32 | 2.54 | 14.97 | 0.4778 | 1.45 | 1.45 | 70.91 | 13.26 | 1.90 | 8.79 | 8.35 | 2,623,037.00 | 3.94 | 4.32 | 6.35 | 7.62 | 12.49 | 11.47 | 2.08 | 1.98 | 0.7358 | 6.79 | 0.4402 | 76.77 | 14.00 | 11.86 | 25.06 | 13.04 | 11.11 | 10.05 |
| China Resources Pharmaceutical Group Ltd | 55.31bn | 871.24m | 7.61bn | 72.99k | 8.73 | 0.7321 | 3.08 | 0.1375 | 0.6621 | 0.6621 | 42.04 | 7.90 | 1.06 | 7.06 | 3.84 | 3,618,589.00 | 3.36 | 3.02 | 12.72 | 11.35 | 15.67 | 15.72 | 3.18 | 2.87 | 1.09 | 8.70 | 0.412 | 24.73 | 12.16 | 8.86 | 10.11 | 2.80 | 13.58 | 7.05 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 09 May 2024 | 5.95m | 3.08% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2024 | 4.49m | 2.33% |
| Accident Compensation Corp.as of 25 Jul 2023 | 4.00m | 2.07% |
| Guardians of New Zealand Superannuationas of 30 Jun 2023 | 3.29m | 1.70% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 2.74m | 1.42% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 2.33m | 1.21% |
| ANZ New Zealand Investments Ltd.as of 25 Jul 2023 | 2.21m | 1.14% |
| BlackRock Fund Advisorsas of 04 Jun 2024 | 2.04m | 1.05% |
| Smartshares Ltd.as of 30 Apr 2024 | 2.03m | 1.05% |
| BlackRock Investment Management (Australia) Ltd.as of 04 Jun 2024 | 1.29m | 0.67% |
